What Did Google Confirm, and What Is Still Unreported?
Google confirmed a limited test. Adweek reported at 6:00 a.m. ET on October 12, 2026 that Google is testing ads for branded prescription drugs in AI Mode and AI Overviews, “the company confirmed to ADWEEK” (Adweek). The story covers both surfaces, so a description that mentions only AI Mode understates the test.
| Question | What the sources say | Source |
|---|---|---|
| Who confirmed it? | A Google spokesperson, to Adweek | Adweek |
| When did it start? | “This month” (October 2026); no exact day in the text we could read | Adweek |
| Where? | Limited to the U.S. | Adweek |
| Which surfaces? | AI Mode and AI Overviews | Adweek |
| Which ad formats? | Standard text and Shopping ads | Adweek |
| How are they labeled? | In sections labeled “Sponsored” | Adweek |
| Which drugs, advertisers and queries? | Not stated in the readable text; Google says “certain pharmaceutical products” | Adweek |
| Is there a Google page for the test? | We found none on October 12, 2026 | None |
The Adweek article is behind a subscription wall. We read the opening paragraphs, which carry Google's confirmation, the U.S. limit, the formats and the label, and the spokesperson's statement. Anything beyond them is outside this guide.
What Do Google's Own Ads Pages Say?
They have not caught up. Google's help page “About ads and AI Overviews,” read on October 12, 2026, says: “Currently, we don’t show ads in AI Overviews for sensitive verticals like adult, alcohol, gambling, finance, healthcare, politics, and more” (Google Ads Help). The spokesperson's statement to Adweek describes a recent expansion to “certain pharmaceutical products”, so the help page and the test now point in different directions. We would treat the help page as the general rule and the test as a documented exception that Google has described only to the press.
The same page explains how ads in AI Overviews work generally. Ads can show above or below an AI Overview in “all 200+ markets where AI Overviews are available.” Ads within AI Overviews are available in English in 12 listed countries, including the US. “Both the user query as well as the content of the AI Overview are considered when serving these ads,” and text and Shopping ads from existing Search, Shopping and Performance Max campaigns are eligible (Google Ads Help). Its FAQ adds three points that matter to a buyer: an advertiser cannot directly target the AI Overviews placement, cannot opt out of it, and gets no segmented reporting for it; ads there are reported as Top Ads.
The page does not describe the “Sponsored” label, and we did not find a Google help page for ads in AI Mode, so the label description in this guide rests on Adweek alone.
What Does Google Already Allow Pharmaceutical Advertisers to Do?
The test sits on top of an existing healthcare policy. Google says “ads and destinations are expected to follow appropriate laws and industry standards,” and that some healthcare content can only be advertised in certain locations by advertisers who have applied and been approved (Google Advertising Policies Help). For drug makers specifically, “Pharmaceutical manufacturers may promote prescription drugs in the following locations”: Canada, New Zealand and the United States. “Pharmaceutical manufacturers may not promote prescription opioid painkillers,” and “Pharmaceutical manufacturers must be certified by Google in order to serve ads” (Google Advertising Policies Help).
locations listed
Source: Google, "Pharmaceutical manufacturers," Advertising Policies Help; Google, "About ads and AI Overviews," Google Ads Help; Adweek, "Google Opens AI Mode to Prescription Drug Ads," October 12, 2026. Read October 12, 2026.
Counts are ours; the lists are Google's. The AI Overviews row counts countries where ads can show within an AI Overview in English (ads above or below AI Overviews run in all 200+ markets where AI Overviews are available). The test row reflects the spokesperson's statement that the test is limited to the U.S.; it is not a policy list. The policy pages we read do not mention AI Mode or AI Overviews.
The prescription list is far shorter than the over-the-counter list, and the reported test covers one of its three countries. The policy pages we read do not mention AI Mode or AI Overviews. Our inference, not a Google statement, is that the same certification and location rules govern the test.
Is a Paid Ad in an AI Answer the Same as an Earned Citation?
No. A Sponsored section is advertising, bought under Google's ad policies and, for drug makers, after certification. A source link or mention inside the generated answer is a separate matter. Per Adweek, the ads sit in their own labeled sections, which indicates Google presents them apart from the answer. Nothing in the sources we read says that running an ad changes which sources an AI answer cites; a buyer should not assume it does, and no seller should imply it. For how AI Overviews treat the sources they do cite, see do AI Overviews say what their sources say, and for the two surfaces compared, Google AI Overviews vs AI Mode.
| Feature | Paid ad in AI Mode or AI Overviews | Earned citation or mention |
|---|---|---|
| How it appears | In a section labeled Sponsored (Adweek) | Inside or linked from the generated answer |
| Who decides | The ad auction, within Google's ad policies and certification | Google's systems, not the advertiser |
| Can money buy it? | Yes, that is what an ad is | We found no source saying an ad changes it |
| Can the advertiser choose the slot? | No; AI Overviews placement cannot be targeted or opted out of (Google Ads Help) | Not applicable |
Why Is Prescription Drug Advertising Treated Differently?
Google itself sets the category apart, through certification and a three-country list for prescription drugs. Adweek calls it “one of the most tightly regulated categories in advertising” (Adweek). Google also treats health as “Your Money or Your Life” territory in its search quality guidance; see what YMYL means.
We did not read U.S. Food and Drug Administration or Federal Trade Commission guidance on prescription drug advertising for this guide, so we state no rule on what such an ad must include. Any pharmaceutical company running these ads should take that question to its regulatory counsel. This is not legal advice.
What This Means for Anyone Buying a Placement
Four practical points follow; they are our recommendations, not platform rules.
- Treat an AI Mode or AI Overviews ad as an ad. It carries a Sponsored label and should be planned, budgeted and reported as paid media, not as coverage.
- Do not buy it expecting citations. We found no source linking ad spend to organic AI citations. Any pitch that does should be asked for Google's documentation.
- Check certification and the help pages first. Google requires drug makers to be certified, and its AI Overviews ads page still lists healthcare as excluded, so ask Google which rule applies to your account.
- Keep earned and paid reporting separate. A paid article or sponsored post is also advertising and must be disclosed as such (see what the FTC requires for paid placement). Never describe a placement as guaranteeing AI visibility.
Methodology and Limitations
Four limits apply. First, the Adweek article is paywalled and we read only its opening paragraphs, so details further down, such as named advertisers or drug categories, are missing. Second, the test rests on one trade-press report and one Google statement relayed through it; we found no Google announcement or help page for it on October 12, 2026. Third, the Sponsored label is described by Adweek alone; we did not see the ads. Fourth, a test can change or end at any time, and nothing here predicts a wider rollout.
Conclusion
Google is testing prescription drug ads in AI Mode and AI Overviews in the U.S., in standard text and Shopping formats inside sections labeled Sponsored, according to its own confirmation to Adweek. For buyers, the uncomfortable point is how little is documented: Google's AI Overviews ads page still says healthcare is excluded, and advertisers can neither target nor opt out of the placement nor see it reported separately. Until Google documents the test, treat these ads as advertising, treat citations as a separate question, and do not accept any claim that one buys the other.
Frequently Asked Questions
Is Google showing ads for prescription drugs in AI Mode?
Yes, in a test. A Google spokesperson told Adweek that testing for pharmaceutical products, including prescription drugs, began in October 2026 and is limited to the U.S. (Adweek, October 12, 2026).
Does the test include AI Overviews as well as AI Mode?
Yes. The spokesperson's statement names both: “We’re testing standard text and Shopping ads in AI Mode and AI Overviews, which we recently expanded to include certain pharmaceutical products” (Adweek).
How are prescription drug ads labeled in Google's AI answers?
Adweek reports that the ads appear in sections labeled Sponsored. We found no Google help page describing the label's design or placement, so we do not describe those details.
Doesn't Google exclude healthcare ads from AI Overviews?
Its help page “About ads and AI Overviews” still said so on October 12, 2026, listing healthcare among sensitive verticals where it does not show ads in AI Overviews. The spokesperson's statement to Adweek describes a recent expansion to certain pharmaceutical products, so the test appears to be an exception the help page does not yet reflect.
Can paying for a Google ad get a brand cited in AI Mode answers?
We found no source saying so. A Sponsored ad is advertising, and nothing we read links ad spend to which sources an AI answer cites. No one should promise citations as the outcome of a purchase.
Which drug makers can advertise prescription drugs on Google?
Google's policy says pharmaceutical manufacturers must be certified by Google and may promote prescription drugs only in Canada, New Zealand and the United States, and may not promote prescription opioid painkillers (Google Advertising Policies Help). This is not legal advice.
Sources
Built from the opening paragraphs of Adweek's October 12, 2026 report, which are the only part available without a subscription, and from three Google help pages on healthcare advertising, pharmaceutical manufacturers and ads in AI Overviews, all read on October 12, 2026. Statements marked as our inference or recommendation are house views, not Google rules. We did not read FDA or FTC guidance, and we did not see or test the ads.
- trade press Adweek, Trishla Ostwal, Google Opens AI Mode to Prescription Drug Ads, October 12, 2026. Supports the test, its start month, U.S. limit, surfaces, formats, Sponsored label and the Google spokesperson's statement. Opening paragraphs only; paywalled. Read October 12, 2026.
- platform documentation Google Ads Help, About ads and AI Overviews. Supports the healthcare exclusion wording, markets, eligible formats, targeting, opt-out and reporting limits. Read October 12, 2026.
- platform documentation Google Advertising Policies Help, Healthcare and medicines. Supports the laws-and-standards expectation and approved-advertiser framing. Read October 12, 2026.
- platform documentation Google Advertising Policies Help, Pharmaceutical manufacturers. Supports the prescription, over-the-counter and supplier location lists, the opioid exclusion and the certification requirement. Read October 12, 2026.